GlassScriptPhysician profile
Dawna L Jones
NPI 1316091465
$741.30
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $95.99 · 2021: $131 · 2022: $14.94.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $246.88 | 2019-2021 | |
| Therapeuticsmd, INC. | $236.76 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $150.43 | 2019-2021 | |
| Ibsa Pharma INC. | $42.91 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.51 | 2021-2022 | |
| Medtronic Vascular, INC. | $16.93 | 2020 | |
| Evofem Biosciences, INC. | $16.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawna Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.